Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Browse By Topic
Recommended Topics
View All Topics
Economics & Value
First National Study: Geographic Socioeconomic Disparities Mirror Substantial Gaps in Survival in Children with AML
Chase Doyle
Real-World Healthcare Utilization and Costs Support Broader Use of CAR T-Cell Therapy
Phoebe Starr
Value-Based Care Management Medicare Program Changes for 2020 and Beyond
Joseph S. Bailes, MD
,
Gena Cook
View More Articles
Personalized Medicine
Loss of Y Chromosome in Men Makes Bladder Cancer More Aggressive
Nadia Jaber
Liquid Biopsies on the Horizon for Children With Solid Cancers
Ella Ben-Ari
Recent Developments in Genomic-Driven Therapies for Cholangiocarcinoma
View More Articles
Value in Oncology
NCCN Panel Debates Cancer Care in Value-Based Healthcare Models
Wayne Kuznar
FDA Implements New Steps to Encourage Generic Drug Competition, Expand Patients’ Access to Inexpensive Medicines
Eileen Koutnik-Fotopoulos
Rapid Adoption of Oncology Drugs Improves Survival
Chase Doyle
View More Articles
FDA Approvals, News & Updates
Fruzaqla FDA Approved for Relapsed Metastatic Colorectal Cancer
FDA Approved Loqtorzi, a PD-1 Inhibitor, for the Treatment of Metastatic or Recurrent Nasopharyngeal Carcinoma
Keytruda Plus Chemotherapy Receives New FDA Approvals for Advanced Biliary Tract Cancer and 2 Forms of GEJ Adenocarcinoma
View More Articles
Emerging Therapies
Zanidatamab Demonstrates Efficacy in Refractory HER2-Amplified Biliary Tract Cancer
Investigational mRNA-Based Vaccine May Offer New Hope for Patients With High-Risk Melanoma
Phoebe Starr
First-Line Mosunetuzumab Safe and Effective in Older Patients with Diffuse Large B-Cell Lymphoma
Chase Doyle
View More Articles
Immunotherapy
Immunotherapy After Surgery Shows Long-Term Benefits for High-Risk Bladder Cancer
Sharon Reynolds
Personalized Vaccine plus Immune Checkpoint Inhibitor a Promising Approach to Cancer
Phoebe Starr
FDA Grants Priority Review to Keytruda for Patients with High-Risk, Non–Muscle-Invasive Bladder Cancer
Yvette Florio Lane
View More Articles
2018 AONN+ Midyear Conference
2021 Summit
2022 Summit
2023 AONN+ Midyear Conference
AACR 2023 Annual Meeting
AACR COVID-19 Highlights
ASCO 2021 Highlights
ASCO 2022 Highlights
ASCO 2023 Highlights
ASCO GI 2022 Highlights
ASCO GU 2022 Highlights
ASCO GU 2023 HIGHLIGHTS
ASH 2021 - Myelofibrosis
ASH Highlights
ASTRO Meeting Highlights
Attendees Only Videos
AVBCC
AVBCC COVID-19 Webcast Series Coverage
AVBCC COVID-19 Webcast Series Replays
AVBCC Special Feature
Biomarkers
Biosimilars
Brain Cancer
Cancer Awareness
Cancer Center Profile
Cancer Moonshot
Cancer Pain
Cholangiocarcinoma
CINV Management
Clinical Pathways
Collaborative Care
Continuing Education
COVID-19
COVID-19 & Cancer
Cybersecurity
Disparities in Cancer Care
Disparities in Oncology
Drug Updates
Economics & Value
Editorial
Endometrial Cancer
ESMO 2020 Highlights
ESMO 2022 Highlights
ESMO 2023 Highlights
FDA Approvals, News & Updates
Financial Toxicity
From the Editor
Gastrointestinal Cancers
General News
Genetic Counseling
Genomic Testing
Geriatric Cancer
Graft-Versus-Host Disease
Health Disparities
Healthcare Administration
Healthcare Equity
Healthcare Technology
Hematologic Cancers
Hepatocellular Carcinoma
In the Literature
In the News
Integrated Care Models
Interview with the Innovators
JCP Special Report
Lymphoma
Lynch Syndrome
Maintenance Therapy
Medical Marijuana
Mesothelioma
Metastatic Cancer
MOA Magnifiers
Multiple Myeloma
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
NCCN 2020 Hematologic Malignancies
NCCN 2022 Hematologic Malignancies
NCCN 2023 Conference Highlights
Neuroendocrine Tumors
News Briefs
Oncology Care Model
Oncology News
Oncology Practice
Oral Oncolytics
Patient Support Services
Pediatric Cancer
Personalized Medicine
Policies & Guidelines
Prostate Cancer Diagnostics
Rectal Cancer
Renal-Cell Cancer
Renal-Cell Carcinoma
SABCS Highlights
Side-Effects Management
Skin Cancer
Social Determinants
Specialty Pharmacy
Supportive Care 2019 Symposium
Symptom Management
Synovial Sarcoma
Targeted Therapy
Urothelial Cancer
USP 800 Compliance
Value Peer-spectives
Webinars
Women's Health
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani
,
Arva Patel
,
Warner Kornberg
,
Asutosh Gor, MD
,
Sashi Naidu, MD
,
Viral Rabara, MD
,
Niyati Nathwani, MD
,
Kashyap Patel, MD
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
Talvey Receives Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma